EVLV Evolv Technologies Holdings, Inc. Insider Trading

Chief Revenue Officer Robert Marshall buys 7,000 shares of EVLV at $6.06; cluster pattern with 3 other insiders buying within 14 days

Robert Marshall, Chief Revenue Officer of Evolv Technologies, purchased 7,000 shares at $6.06 on 2025-11-25, establishing an initial position in the stock. The transaction occurred in the context of a cluster buy pattern, with 3 other insiders also purchasing within the past 14 days. The company is unprofitable (full-year net income was negative) but shows strong top-line growth of 29.2% annually, and trades at $6.20 currently—down 29.2% from its 52-week high of $8.76. The synchronized buying activity by multiple executives at depressed levels relative to recent highs suggests coordinated confidence in the underlying business fundamentals despite current profitability challenges.

CEO John Kedzierski buys 8,000 shares at $5.91; cluster pattern shows 3 insiders buying within 14 days

John Kedzierski, President & CEO of Evolv Technologies, purchased 8,000 shares at $5.91 on 2025-11-21, establishing an initial position of 8,000 shares. This buy occurs within a cluster: 2 other insiders also purchased shares within the past 14 days, suggesting coordinated accumulation at the company level. The stock has declined -24.7% over the past 30 days and -25.3% over 90 days, trading 29.2% below its 52-week high. The company reported revenue of $42.8M with annual growth of 29.2%, but it remains unprofitable, posting net income of -$1.8M in the most recent quarter and negative full-year earnings. The cluster buy pattern at a depressed price point, combined with the company's revenue growth trajectory and unprofitable status, warrants investor attention to the strategic context behind this concurrent insider accumulation.

Director Charlton Kevin M. bought 15,000 shares of EVLV at $5.68; holdings increased 51.6% to 44,081 shares amid cluster buy by 2 others in past 14 days.

Director Charlton Kevin M. purchased 15,000 shares at $5.68 on 2025-11-21, expanding his holdings by 51.6% to 44,081 shares total, while two other insiders also bought within the past 14 days. The stock has declined 23.2% in the past 30 days and 29.0% over 90 days from a 52-week high of $8.76, trading 32.2% below that peak. The company generated $42.8M in quarterly revenue with +29.2% annual growth, but posted a $-1.8M net loss and remains unprofitable on a full-year basis. The cluster buy pattern during a period of significant stock weakness, combined with negative recent price momentum and ongoing unprofitability, presents a material signal requiring deeper assessment of insider motivation relative to recent company performance.

Director Shapiro buys 46,300 shares for $278,126.00 at $6.01 avg; stock down 29.2% in 30 days, now $5.66.

Richard A Shapiro, a Director at Evolv Technologies, executed 3 separate purchases totaling 46,300 shares for $278,126.00 on 2025-11-20 at a blended average price of $6.01, against a current price of $5.66. The stock has declined 29.2% over the past 30 days and 32.4% over 90 days, trading 35.4% below its 52-week high. The company generated $42.8M in revenue last quarter with annual growth of 29.2%, but reported a net loss of $1.8M in the most recent quarter and negative full-year net income. Shapiro's post-transaction holdings are 16,400 shares; the position moved from short (-29,900 shares) to long, representing a substantial commitment of capital at price levels that have since depreciated. This purchase pattern—multiple tranches at proximate prices during a period of material price weakness—merits examination against EVLV's operational trajectory and the director's prior activity at the company.

Founder Anil Chitkara sells 360,000 EVLV shares (22.0% of holdings) for $2,952,000 via scheduled 10b5-1 plan

Chitkara, Founder & Chief Growth Officer, executed four separate sales totaling 360,000 shares (360.0K shares) for $2,952,000.00 on October 24 and October 27, 2025, all at $8.20 per share. This represents a 22.0% reduction in his holdings, from 1,635,100 shares to 1,275,100 shares post-transaction. The sales were executed pursuant to a pre-arranged 10b5-1 trading plan, indicating these were scheduled transactions rather than discretionary decisions. As a founder and senior executive, Chitkara's substantial share disposition warrants investor attention to understand whether these scheduled sales reflect prior-planned portfolio management or signal broader context about the company's trajectory.

Gates Frontier LLC sells 1,470,700 shares at $8.12 avg; still holds 17.19M (58% of pre-transaction) in unprofitable EVLV

Gates Frontier, a 10% owner, conducted 2 separate sales totaling 1,470,700 shares for $11,945,525.32 between September 10-11, reducing holdings by 7.9% to 17.19M shares. The sale occurred near the 52-week high of $8.76, with the blended average price of $8.12 representing favorable execution during a strong recent rally (+17.0% over 30 days, +73.5% over 90 days). Despite the substantial reduction, the filer retains a material 17.19M share position in a company currently unprofitable (full-year net income was negative) with recent quarterly net losses of $40,535,000.00 against quarterly revenue of $32,544,000.00, signaling ongoing operational challenges that the partial liquidation does not fully resolve.

Director David Gonzales buys 50,000 shares of EVLV at $3.00 on 2024-08-13, raising stake to 120.5K shares (+70.9%).

Director Gonzales purchased 50,000 shares at $3.00 on 2024-08-13, more than doubling his equity stake from 70.5K to 120.5K shares. The purchase occurred at a price 61.6% below the 52-week high of $7.94, reflecting the stock's recent weakness; the current price of $3.05 shows minimal change from the transaction price. Gonzales's prior buy at this ticker on 2024-03-06 delivered a 90-day return of -32.6%, establishing a pattern of underperformance: his cross-ticker track record shows a 0.00% 90-day win rate across 1 prior buy. The company is generating substantial revenue growth (annual growth +45.7%) and reported positive net income of $3.5M in the latest quarter, yet remains unprofitable on a full-year basis, creating tension between near-term earnings and ongoing structural losses.

Director Glat Neil buys 8,333 shares of EVLV at $3.00 (stock down -61.6% from 52-week high)

Glat Neil, a director of Evolv Technologies, purchased 8,333 shares at $3.00 on 2024-08-14, increasing his holdings to 162,355 shares (+5.4% of pre-transaction position). The purchase occurs at a 1.6% discount to current price ($3.05) and represents a discrete director investment while the stock trades substantially depressed—down 61.6% from its 52-week high of $7.94, though up 11.3% over the prior 90 days. The company reported strong top-line momentum with +45.7% annual revenue growth and $3.5M net income in the latest quarter, yet carried negative full-year profitability in the most recent complete fiscal year. This purchase by a board member during a period of depressed valuation—paired with documented quarterly profitability—merits attention as a data point on insider appetite at current levels, though the transaction size is modest relative to both director holdings and overall market cap.